DOI: http://dx.doi.org/10.18203/2349-3933.ijam20201617

A study of correlation of serum albumin with dengue severity

Thyagaraj ., Sreedevi T.

Abstract


Background: Dengue viruses are flavivirus, which include four serotypes 1, 2, 3 and 4. Clinical expression of dengue virus infection vary from asymptomatic infection to severe dengue with shock. It is the most rapidly spreading vector borne disease in the world. An estimated 50 million dengue infections occur annually and approximately 2.5 billion people live in dengue endemic countries. The objective of this study was to predict the severity of Dengue illness by correlating the serum albumin levels.

Methods: An observational cross-sectional study done on patients admitted in Basaveshwara Medical College and Research Institute, Chitradurga, Karnataka, a tertiary care Hospital. Patients with Dengue NS1 Ag or IgM positive are included in the study after meeting inclusion and exclusion criteria. Complete Blood count, serum albumin levels are estimated at the time of admission.

Results: Study enrolled 100 patients with confirmed Dengue virus infection who were admitted to the hospital between July 2017 and December 2018. Serum samples taken within 24 hours of admission was used for biochemical tests. Out of 100 patients, 24 developed Severe Dengue. Cases of Severe Dengue had low levels of serum albumin. Multivariate analysis showed that early alterations of albumin i.e. out of 24 patients who developed severe dengue, 21 patients i.e. 92.7% had low albumin of <3gm/dl

Conclusions: Early changes in biochemical parameter, serum albumin can predict Severe Dengue in patients with Dengue febrile illness.


Keywords


Dengue fever, Serum albumin, Severe Dengue

Full Text:

PDF

References


Gubler DJ. Dengue and dengue hemorrhagic fever. Clin Microbiol Rev. 1998 Jul 1;11(3):480-96.

Perez JGR, Clark GG, Gubler DJ, Reiter P, Sanders EJ. Dengue and Dengue hemorrhagic fever. Lancet 1998;352:971-77.

Kuhn RJ, Zhang W, Rossmann MG, Pletnev SV, Corver J, Lenches E, et al. Structure of dengue virus: implications for flavivirus organization, maturation, and fusion. Cell. 2002 Mar 8;108(5):717-25.

Siqueira Jr JB, Martelli CM, Coelho GE, da Rocha Simplício AC, Hatch DL. Dengue and dengue hemorrhagic fever, Brazil, 1981-2002. Emerg Infect Dis. 2005 Jan;11(1):48.

Lee MS, Hwang KP, Chen TC, Lu PL, Chen TP. Clinical characteristics of dengue and dengue hemorrhagic fever in a medical center of southern Taiwan during the 2002 epidemic. J Microbiol, Immunol, Infect= Wei mian yu gan ran za zhi. 2006 Apr;39(2):121-9.

Parrish CR, Krenitsky J, McCray S. University of Virginia Health System Nutrition Support Traineeship Syllabus. Available through the University of Virginia Health System Nutrition Services in January. 2003 Jan.

Seres DS. Surrogate nutrition markers, malnutrition, and adequacy of nutrition support. Nutrit Clini Pract. 2005 Jun;20(3):308-13.

Banh L. Serum proteins as markers of nutrition: what are we treating?. Pract Gastroenterol. 2006;30(10):46.

Villar-Centeno LA, Díaz-Quijano FA, Martínez-Vega RA. Biochemical alterations as markers of dengue hemorrhagic fever. Am J Trop Medi Hyg. 2008 Mar 1;78(3):370-4.

World Health Organization, Special Programme for Research, Training in Tropical Diseases, World Health Organization. Department of Control of Neglected Tropical Diseases, World Health Organization. Epidemic, Pandemic Alert. Dengue: guidelines for diagnosis, treatment, prevention and control. World Health Organization; 2009.

Tantawichien T. Dengue fever and dengue haemorrhagic fever in adolescents and adults. Paediatr Int Child Health. 2012 May 1;32(sup1):22-7.

Jagadishkumar K, Jain P, Manjunath VG, Umesh L. Hepatic involvement in dengue fever in children. Iranian J Pediatr. 2012 Jun;22(2):231-6.